Figure 5 — Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy

Research Paper|Volume 12, Issue 4|pp. 3312–3339

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy

Back to articleFigure 5(5 of 6)

100%

Figure 5.Functional annotation in high-/low-risk subtypes of LUAD. (A) Dysregulation of signaling pathways stratified by identified LUAD subtypes. (B) Expression profiles of cell cycle checkpoint markers in the high-risk group versus low-risk group.